25812-76-4

Basic information

• Product Name: 4-METHYL-3-(METHYLTHIO)-5-PHENYL-4H-1,2,4-TRIAZOLE
• Synonyms: 4-METHYL-3-(METHYLTHIO)-5-PHENYL-4H-1,2,4-TRIAZOLE;BUTTPARK 64\41-01;4-methyl-3-(methylthio)-5-phenyl-1h-1,2,4-triazole;4-triazole,4-methyl-3-(methylthio)-5-phenyl-1h-2
• CAS NO: 25812-76-4
• Molecular Formula: C₁₀H₁₁N₃S
• Molecular Weight: 205.28
• Mol File: 25812-76-4.mol
• Article Data: 4

Chemical Properties

• Melting Point: 138 °C
• Boiling Point: 387.9°C at 760 mmHg
• Flash Point: 188.4°C
• Appearance: /
• Density: 1.21g/cm³
• Vapor Pressure: 3.19E-06mmHg at 25°C
• Refractive Index: 1.639
• PKA: 1.69±0.10(Predicted)
• CAS DataBase Reference: 4-METHYL-3-(METHYLTHIO)-5-PHENYL-4H-1,2,4-TRIAZOLE(CAS DataBase Reference)
• NIST Chemistry Reference: 4-METHYL-3-(METHYLTHIO)-5-PHENYL-4H-1,2,4-TRIAZOLE(25812-76-4)
• EPA Substance Registry System: 4-METHYL-3-(METHYLTHIO)-5-PHENYL-4H-1,2,4-TRIAZOLE(25812-76-4)

Safety Data

• Hazardous Substances Data: 25812-76-4(Hazardous Substances Data)

Usage

InChI:InChI=1/C10H11N3S/c1-13-9(11-12-10(13)14-2)8-6-4-3-5-7-8/h3-7H,1-2H3

Upstream product

• 38942-51-7 4-methyl-3-phenyl-1H-1,2,4-triazole-5(4H)-thione 
• 74-88-4 methyl iodide 
• 855737-98-3 1-benzoyl-4,S-dimethyl-iso thiosemicarbazide 
• 58064-65-6 1-(phenyl)carbonyl-4-(methyl)thiosemicarbazide 
• 613-94-5 benzoic acid hydrazide 

Downstream Products

• 116850-44-3 MDL 27531 
• 116850-60-3 4-methyl-5-methylsulfinyl-3-phenyl-4H-1,2,4-triazole 

Relevant articles and documents

Triazolyl azabicyclo[3.1.0]hexanes: A class of potent and selective dopamine D3 receptor antagonists

Herein we report a detailed description of the structure-activity relationships for a novel series of "C-linked" 1,2,4- triazolylazabicyclo[3.1.0]hexanes. These derivatives are endowed with very high in vitro affinity and selectivity for the dopamine Dsu

3-aryl-5-alkylthio-4H-1,2,4-triazoles

This invention relates to novel sulfone and sulfoxide derivatives of 3-aryl-5-alkylthio-4H-1,2,4-triazoles and to the use of 3-aryl-5-alkylthio-, alkylsulfinyl- and alkylsulfonyl-4H-1,2,4-triazoles in the treatment of patients suffering from convulsant seizures.